This Week in Psychedelics - 11.5.21

Cannabis

  • Voters In Seven Ohio Cities Approve Marijuana Decriminalization Ballot Measures, With Seven Others Defeated (Marijuana Moment)

  • 3 Years Since the UK Legalised Medical Cannabis, and Only 3 NHS Prescriptions (Drug Science)

  • New Congressional Report Provides Pathway for How the Biden Administration Can Deschedule Marijuana and Issue Blanket Pardons to Past Offenders (NORML)

  • Pakistan Vows Cannabis Reform by End of Year (High Times)

  • Strong Majority Of Americans Continues To Support Marijuana Legalization At Record High Level, New Gallup Poll Finds (Marijuana Moment)

  • California legalized weed five years ago. Why is the illicit market still thriving? (The Guardian)

  • Philadelphia Voters Approve Marijuana Referendum Calling For Statewide Legalization (Marijuana Moment)

  • Virginia: Election Outcomes Likely to Influence Marijuana Legalization Launch (NORML)

  • DEA Emboldens Delta-8 Hemp Businesses By Signaling That The Cannabinoid Is Federally Legal (Marijuana Moment)

  • Marijuana Legalization Is Not Associated With Increased Mental Illness Or Suicide, New Study Finds, Despite Opposition Claims (Marijuana Moment)

  • Mississippi Governor Stalls Medical Cannabis Bill (High Times)

  • Legalizing Marijuana Reduces ‘Race-Based Arrests,’ American Medical Association Study Finds (Marijuana Moment)

  • Cannabis growers eye drought-resistant strains to cope with water shortage (Marijuana Business Daily)

  • Arkansas Activists File New Marijuana Legalization Initiative For 2022 Ballot (Marijuana Moment)

  • Medical marijuana could ease anxiety, depressive symptoms, study shows (Marijuana Business Daily)

  • Concentrates and vape products maintain dominance among heavy cannabis users (Marijuana Business Daily)

  • Government-Grown Marijuana Is Genetically Closer To Hemp Than Cannabis Sold In Dispensaries, Another Study Finds (Marijuana Moment)

  • Edibles and beverages are popular choices with new cannabis users (Marijuana Business Daily)

  • Army Recruits Who’ve Used Marijuana ‘Perform No Worse’ Than Other Soldiers, Military-Funded Report Finds (Marijuana Moment)

Magic Mushrooms

  • World-first trial of psilocybin therapy for anxiety disorders to begin in Australia (Happy Mag)

  • Psilocybin-assisted psychotherapy might help to reduce attachment anxiety (PsyPost)

  • Microdosing Moms: Psilocybin & Postpartum Depression Relief (Truffle Report)

  • COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for PTSD (Psilocybin Alpha)

  • Psilocybe subaeruginosa: Australia’s Most Famous Magic Mushroom (DoubleBlind)

  • A Case Study on Microdosing and Self-Care (The Third Wave)

  • Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully Added to the Natural Health Products Ingredients Database (NHPID) of Canada (Psilocybin Alpha)

  • The Missing Mushroom: Psychedelic Science and the Future of Psilocybin (Psychedelic Science Review)

  • Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial (Psilocybin Alpha)

  • Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct Psilocin Administration and First-Ever Psychedelic Botanical Drug Candidates (Psilocybin Alpha)

DMT

  • Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study (Psilocybin Alpha)

  • PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases (Psilocybin Alpha)

  • Understanding A DMT Trip: From The Experience To Potential Side Effects (Healing Maps)

Mescaline

  • Mescaline Revelations: Hume, Buddhism, and the Illusory Nature of the Self (Sam Woolfe)

Peyote

Iboga

  • Ibogaine and Iboga: Traditional Use, Conservation, and Ethical Considerations (DoubleBlind)

Morning Glory Seeds

Novel Psychoactive Substances

  • atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort of Phase 2a Trial for Novel Treatment of Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)

Ketamine

  • Ketamine rapidly improves cognitive function, making those in suicidal crisis less likely to harm themselves (Medical Xpress)

  • Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine (Forbes)

  • Klarisana's Newest Ketamine Study Shows IM Ketamine Therapy Comparable to IV Administration (PR Newswire)

  • Study: Mixing CBD With Ketamine Might Be Great For Depression (Forbes)

  • Ketamine Users Can Ensure Safety with DanceSafe’s New Testing Kit (Lucid News)

  • Parents Are Very Open to Ketamine Therapy for Kids, Study Finds (Psychedelic Spotlight)

DXM

  • ‘Robotripping’: Perth teens creating cough syrup cocktails as they chase a cheap high (The Age)

Miscellaneous

  • Detroit Voters Decriminalize Psychedelics, Joining Ann Arbor (DoubleBlind)

  • FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics (Psychedelic Spotlight)

  • The False Promise of Psychedelic Utopia (VICE)

  • Classic Psychedelics Aren’t Addictive (Discover Magazine)

  • Psychedelic Therapy Is Hyped, But It’s Not Risk-Free: How Therapy Abuse Can Retraumatize Clients (Forbes)

  • New Orleans shoeshine man wins legal battle over $30,000 seized by DEA agents (NBC News)

  • Washington D.C.’s 1st Year of Psychedelic Decrim (Truffle Report)

  • Statewide Psychedelic Decriminalization Efforts Are Growing Across the Nation (Lucid News)

  • PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics (Yahoo!)

  • Wonderland: Miami Takes Shape as the Largest Psychedelic Medicine Business Event (High Times)

  • Oregon’s Drug Decriminalization Has Raised Over $300 Million for Treatment and Services (Filter)

  • ‘I’ve experienced states of consciousness beyond this life’: The people turning to psychedelics on their deathbeds (The Independent)

  • How the Psychedelic Community Should Respond to Sexual Abuse (Lucid News)

  • Psychedelic Research Beyond Depression & Trauma Part II (Truffle Report)

  • Science Has Shown Me the Way Ahead with Psychedelics (Chacruna)

  • We must address and deconstruct the stigma of psychedelics (The Michigan Daily)

  • How Psychedelics Help with Parenting (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.